rs138497939

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 3P and 13B. PM1PP2BP4_StrongBP6BS1BS2

The NM_001040142.2(SCN2A):ā€‹c.5468A>Cā€‹(p.Asp1823Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000127 in 1,614,062 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1823N) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00017 ( 0 hom., cov: 32)
Exomes š‘“: 0.00012 ( 1 hom. )

Consequence

SCN2A
NM_001040142.2 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 2.89
Variant links:
Genes affected
SCN2A (HGNC:10588): (sodium voltage-gated channel alpha subunit 2) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with four repeat domains, each of which is composed of six membrane-spanning segments, and one or more regulatory beta subunits. Voltage-gated sodium channels function in the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family. Allelic variants of this gene are associated with seizure disorders and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

PM1
In a topological_domain Cytoplasmic (size 229) in uniprot entity SCN2A_HUMAN there are 30 pathogenic changes around while only 7 benign (81%) in NM_001040142.2
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SCN2A. . Trascript score misZ 8.7114 (greater than threshold 3.09). GenCC has associacion of gene with seizures, benign familial infantile, 3, Dravet syndrome, benign familial neonatal-infantile seizures, malignant migrating partial seizures of infancy, complex neurodevelopmental disorder, developmental and epileptic encephalopathy, 11, developmental and epileptic encephalopathy, West syndrome, benign familial infantile epilepsy, episodic ataxia, type 9.
BP4
Computational evidence support a benign effect (MetaRNN=0.012391925).
BP6
Variant 2-165389274-A-C is Benign according to our data. Variant chr2-165389274-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 212131.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2, Benign=1}. Variant chr2-165389274-A-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000171 (26/152218) while in subpopulation EAS AF= 0.00155 (8/5178). AF 95% confidence interval is 0.000768. There are 0 homozygotes in gnomad4. There are 14 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 26 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SCN2ANM_001040142.2 linkuse as main transcriptc.5468A>C p.Asp1823Ala missense_variant 27/27 ENST00000375437.7
SCN2ANM_001371246.1 linkuse as main transcriptc.5468A>C p.Asp1823Ala missense_variant 27/27 ENST00000631182.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SCN2AENST00000375437.7 linkuse as main transcriptc.5468A>C p.Asp1823Ala missense_variant 27/275 NM_001040142.2 P1Q99250-1
SCN2AENST00000631182.3 linkuse as main transcriptc.5468A>C p.Asp1823Ala missense_variant 27/275 NM_001371246.1 Q99250-2

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152100
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00154
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000263
AC:
66
AN:
251248
Hom.:
0
AF XY:
0.000280
AC XY:
38
AN XY:
135792
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00256
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000122
AC:
179
AN:
1461844
Hom.:
1
Cov.:
33
AF XY:
0.000133
AC XY:
97
AN XY:
727220
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00141
Gnomad4 SAS exome
AF:
0.000185
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.0000863
Gnomad4 OTH exome
AF:
0.000166
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152218
Hom.:
0
Cov.:
32
AF XY:
0.000188
AC XY:
14
AN XY:
74410
show subpopulations
Gnomad4 AFR
AF:
0.0000963
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00154
Gnomad4 SAS
AF:
0.000623
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000959
Hom.:
0
Bravo
AF:
0.000178
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoDec 16, 2014- -
Developmental and epileptic encephalopathy, 11 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterFeb 24, 2021- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 19, 2017This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Seizures, benign familial infantile, 3;C3150987:Developmental and epileptic encephalopathy, 11 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 22, 2024- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxJun 24, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.052
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
14
DANN
Benign
0.89
DEOGEN2
Uncertain
0.59
D;.;T;.;D;D;.
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.52
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.64
T;.;T;.;.;.;T
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.012
T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.25
T
MutationAssessor
Benign
0.67
N;N;.;N;N;N;N
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-1.4
N;.;.;.;.;N;N
REVEL
Benign
0.28
Sift
Benign
1.0
T;.;.;.;.;T;T
Sift4G
Benign
0.37
T;.;.;T;.;T;T
Polyphen
0.0
B;B;.;B;B;B;B
Vest4
0.11
MVP
0.41
ClinPred
0.024
T
GERP RS
0.28
Varity_R
0.26
gMVP
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138497939; hg19: chr2-166245784; API